Glenview Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $33.2M | Hold |
|
|||||
|
2025
Q2 | $24.4M | Buy |
|
|||||
|
2025
Q1 | $34.6M | Sell |
|
|||||
|
2024
Q4 | $57M | Buy |
|
|||||
|
2024
Q3 | $34.6M | Sell |
|
|||||
|
2024
Q2 | $91.7M | Sell |
|
|||||
|
2024
Q1 | $105M | Sell |
|
|||||
|
2023
Q4 | $101M | Buy |
|
|||||
|
2023
Q3 | $60.7M | Buy |
|
|||||
|
2023
Q2 | $86.8M | Sell |
|
|||||
|
2023
Q1 | $97.5M | Buy |
|
|||||
|
2022
Q4 | $44.9M | Buy |
|
|||||
|
2022
Q3 | $27.9M | Sell |
|
|||||
|
2022
Q2 | $30.8M | Sell |
|
|||||
|
2022
Q1 | $43.8M | Buy |
|
|||||
|
2021
Q4 | $46.4M | Sell |
|
|||||
|
2021
Q3 | $72.2M | Sell |
|
|||||
|
2021
Q2 | $75.7M | Sell |
|
|||||
|
2021
Q1 | $78.2M | Sell |
|
|||||
|
2020
Q4 | $72.8M | Buy |
|
|||||
|
2020
Q3 | $36M | Buy |
|
|||||
|
2020
Q2 | $20.5M | Buy |
|
|||||
|
2020
Q1 | $22M | Sell |
|
|||||
|
2019
Q4 | $93.8M | Sell |
|
|||||
|
2019
Q3 | $105M | Buy |
|